| |
| |
|
| Insider
Information: |
James Michael C |
| Relationship: |
Officer |
| City: |
Providence |
| State: |
RI |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
3,048,439 |
|
|
Indirect Shares
|
13,624,895 |
|
|
| Direct
Value |
$853,440 |
|
|
|
Indirect Value
|
$168,120 |
|
|
| Total
Shares |
16,673,334 |
|
|
| Total
Value |
$1,021,560 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-2.0
|
0.0
|
| Percentage
Gain/Loss : |
 -59.8%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nestor Inc |
NEST |
Director |
2007-07-27 |
5,000 |
2007-07-27 |
796,527 |
Premium* |
|
|
Inergetics Inc |
NRTI |
Director |
|
0 |
2009-09-24 |
12,000,000 |
Premium* |
|
|
Guided Therapeutics Inc |
GTHP |
|
2022-09-02 |
112,772 |
2012-08-21 |
348,368 |
Premium* |
|
|
Unrivaled Brands, Inc |
UNRV |
|
2020-04-14 |
66,667 |
|
0 |
Premium* |
|
|
Edible Garden Ag Inc |
EDBL |
Chief Financial Office... |
2022-09-14 |
1,592,000 |
2022-09-14 |
480,000 |
Premium* |
|
|
Luxurban Hotels Inc |
LUXH |
Officer |
2024-06-04 |
1,272,000 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
393 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 16
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| UNRV |
Unrivaled Brands, Inc |
Chief Financial Officer |
• – – |
2017-04-12 |
4 |
S |
$0.25 |
$50,600 |
D/D |
(200,000) |
0 |
0 |
- |
|
| GTHP |
Guided Therapeutics Inc |
Director |
– • – |
2011-08-23 |
4 |
D |
$0.81 |
$10,125 |
I/I |
(12,500) |
1,026 |
0 |
- |
|
| NEST |
Nestor Inc |
Director |
– • – |
2007-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| GTHP |
Guided Therapeutics Inc |
Director |
– • – |
2010-03-31 |
4/A |
A |
$0.98 |
$25,725 |
D/D |
26,250 |
26,250 |
0 |
- |
|
| GTHP |
Guided Therapeutics Inc |
Director |
– • – |
2010-11-18 |
4 |
S |
$0.81 |
$16,200 |
D/D |
(20,000) |
26,250 |
0 |
- |
|
| GTHP |
Guided Therapeutics Inc |
Director |
– • – |
2010-11-17 |
4 |
S |
$0.80 |
$16,000 |
D/D |
(20,000) |
46,250 |
0 |
- |
|
| GTHP |
Guided Therapeutics Inc |
Director |
– • – |
2011-11-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,500 |
63,750 |
0 |
- |
|
| GTHP |
Guided Therapeutics Inc |
Director |
– • – |
2010-03-15 |
4/A |
OE |
$0.00 |
$0 |
D/D |
65,000 |
65,000 |
0 |
- |
|
| GTHP |
Guided Therapeutics Inc |
Director |
– • – |
2010-11-16 |
4 |
S |
$0.80 |
$20,000 |
D/D |
(25,000) |
66,250 |
0 |
- |
|
| UNRV |
Unrivaled Brands, Inc |
Former Chief Financial Officer |
– – – |
2020-04-14 |
4 |
D |
$0.07 |
$21,110 |
D/D |
(300,000) |
66,667 |
0 |
- |
|
| GTHP |
Guided Therapeutics Inc |
|
– • • |
2022-09-02 |
4 |
B |
$0.00 |
$0 |
D/D |
100,000 |
112,772 |
0.01 |
- |
|
| UNRV |
Unrivaled Brands, Inc |
Chief Financial Officer |
• – – |
2016-05-25 |
4 |
S |
$0.31 |
$78,167 |
D/D |
(250,000) |
200,000 |
0 |
- |
|
| UNRV |
Unrivaled Brands, Inc |
Chief Financial Officer |
• – – |
2017-06-30 |
4 |
A |
$0.23 |
$56,468 |
D/D |
244,133 |
244,133 |
0 |
- |
|
| NEST |
Nestor Inc |
Director |
– • – |
2006-08-21 |
4 |
B |
$2.68 |
$17,267 |
I/I |
6,000 |
275,461 |
2.1 |
- |
|
| NEST |
Nestor Inc |
Director |
– • – |
2006-08-23 |
4 |
B |
$3.04 |
$57,746 |
I/I |
18,600 |
294,061 |
2.1 |
- |
|
| UNRV |
Unrivaled Brands, Inc |
Chief Financial OfficerOfficer |
• – – |
2012-04-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
300,000 |
|
- |
|
| NEST |
Nestor Inc |
Director |
– • – |
2006-07-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
303,461 |
|
- |
|
| NEST |
Nestor Inc |
Director |
– • – |
2006-11-27 |
4 |
B |
$1.27 |
$17,737 |
I/I |
13,580 |
307,641 |
2.1 |
- |
|
| NEST |
Nestor Inc |
Director |
– • – |
2006-11-28 |
4 |
B |
$1.28 |
$5,163 |
I/I |
4,000 |
311,641 |
2.1 |
- |
|
| NEST |
Nestor Inc |
Director |
– • – |
2006-12-11 |
4 |
B |
$1.25 |
$27,131 |
I/I |
20,000 |
331,641 |
2.1 |
- |
|
| GTHP |
Guided Therapeutics Inc |
Director |
– • – |
2012-08-21 |
4 |
D |
$0.71 |
$7,100 |
I/I |
(10,000) |
348,368 |
0 |
- |
|
| GTHP |
Guided Therapeutics Inc |
Director |
– • – |
2012-08-20 |
4 |
D |
$0.70 |
$17,703 |
I/I |
(25,000) |
358,368 |
0 |
- |
|
| UNRV |
Unrivaled Brands, Inc |
Former Chief Financial Officer |
– – – |
2020-04-13 |
4 |
D |
$0.07 |
$14,080 |
D/D |
(200,000) |
366,667 |
0 |
- |
|
| GTHP |
Guided Therapeutics Inc |
Director |
– • – |
2012-08-15 |
4 |
D |
$0.84 |
$10,615 |
I/I |
(12,500) |
383,368 |
0 |
- |
|
| GTHP |
Guided Therapeutics Inc |
Director |
– • – |
2012-08-08 |
4 |
D |
$0.84 |
$5,460 |
I/I |
(6,500) |
395,868 |
0 |
- |
|
393 Records found
|
|
Page 1 of 16 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
